BMRN vs CHRD · P/E 40, rev $2.85B vs rev $5.25B
Biomarin Pharmaceutical Inc (BMRN) versus Chord Energy Corp (CHRD) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Chord Energy Corp (CHRD) is a oil & gas e&p company listed on NASDAQ.
Latest reported BMRN revenue for 2024-12-31 was $2.85B. Net income was $426.9M. Revenue was up 18.0% from 2023-12-31 to 2024-12-31. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported CHRD revenue for 2024-12-31 was $5.25B. Net income was $848.6M. Revenue was up 34.8% from 2023-12-31 to 2024-12-31. CHRD currently screens at market cap $7.15B.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. CHRD currently screens at market cap $7.15B.
Not investment advice. Open the BMRN and CHRD stock pages for the full models.
Not investment advice.